• Explore /
  • Poster
  • / A phase II study of chemotherapy and immune checkpoint blockade with pembrolizumab in the perioperative and maintenance treatment of locoregional gastric or GE junction adenocarcinoma.

A phase II study of chemotherapy and immune checkpoint blockade with pembrolizumab in the perioperative and maintenance treatment of locoregional gastric or GE junction adenocarcinoma.

Abstract Poster

Authors

Paul Oberstein

Paul Eliezer Oberstein

Columbia University Medical Center, New York, NY

Paul Eliezer Oberstein , Beth Schrope , Tamas Gonda , Amrita Sethi , Arnold Han , Gary K. Schwartz , Manish A. Shah

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT02918162

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr TPS197)

DOI

10.1200/JCO.2018.36.4_suppl.TPS197

Abstract #

TPS197

Poster Bd #

M11

Abstract Disclosures

Similar Posters

First Author: Maria E. Cabanillas

First Author: Josep Tabernero

First Author: Samuel J Klempner

First Author: Rui-hua Xu